DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Carcinoma D002277 18 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Dementia D003704 2 associated lipids
Heart Failure D006333 36 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Brain Neoplasms D001932 15 associated lipids
Hypothyroidism D007037 32 associated lipids
Vision Disorders D014786 10 associated lipids
Melanoma D008545 69 associated lipids
Pain, Postoperative D010149 13 associated lipids
Asthma D001249 52 associated lipids
Kidney Diseases D007674 29 associated lipids
Weight Gain D015430 101 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Johnson B Consciousness reinstated using the certainty principle--a better mental health strategy. 2011 Nutr Health pmid:22141192
Golfetto I et al. Fatty acid composition of milk of refugee Karen and urban Korean mothers. Is the level of DHA in breast milk of Western women compromised by high intake of saturated fat and linoleic acid? 2007 Nutr Health pmid:18087864
Cole GM and Frautschy SA Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model. 2006 Nutr Health pmid:17180870
Yavin E Docosahexaenoic acid: a pluripotent molecule acting as a membrane fluidizer, a cellular antioxidant and a modulator of gene expression. 2006 Nutr Health pmid:17180871
Crawford MA Docosahexaenoic acid in neural signaling systems. 2006 Nutr Health pmid:17180872
House S Stages in reproduction particularly vulnerable to xenobiotic hazards and nutritional deficits. 2000 Nutr Health pmid:11028931
Moodley T et al. Arachidonic and docosahexaenoic acid deficits in preterm neonatal mononuclear cell membranes. Implications for the immune response at birth. 2009 Nutr Health pmid:19835110
Ben-Youssef S et al. Total lipids and fatty acids composition of the coastal and the deep-sea common octopus (Octopus vulgaris) populations: a comparative study. 2008 Nutr Health pmid:19009741
Yavin E et al. Docosahexaenoic acid sources for the developing brain during intrauterine life. 2001 Nutr Health pmid:12003088
Saugstad LF Human nature is unique in the mismatch between the usual diet and the need for "food for the brain" (marine fat, DHA). Adding marine fat is beneficial in schizophrenia and manic-depressive psychosis. This underlines brain dysfunction in these neurological disorders is associated with deficient intake of marine fat(DHA). 2002 Nutr Health pmid:12083411
McCowen KC et al. A simple method of supplementation of omega-3 polyunsaturated fatty acids: use of fortified yogurt in healthy volunteers. 2010 Nutr Clin Pract pmid:21139129
Bowden RG et al. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. 2009 Aug-Sep Nutr Clin Pract pmid:19461006
Wiese DM et al. The effects of an oral supplement enriched with fish oil, prebiotics, and antioxidants on nutrition status in Crohn's disease patients. 2011 Nutr Clin Pract pmid:21775642
Nochera CL et al. Consumption of DHA + EPA by low-income women during pregnancy and lactation. 2011 Nutr Clin Pract pmid:21724916
Woods MN Role of n-3 fatty acids in prevention of disease complications in patients with HIV. 2005 Jan-Mar Nutr Clin Care pmid:15850231
Kikawa KD et al. Induced oxidative stress and cell death in the A549 lung adenocarcinoma cell line by ionizing radiation is enhanced by supplementation with docosahexaenoic acid. 2010 Nutr Cancer pmid:21058189
Pardini RS et al. Nutritional intervention with omega-3 Fatty acids in a case of malignant fibrous histiocytoma of the lungs. 2005 Nutr Cancer pmid:16201843
Merendino N et al. Docosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation. 2005 Nutr Cancer pmid:16201853
Macášek J et al. Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. 2012 Nutr Cancer pmid:23061902
Danbara N et al. Conjugated docosahexaenoic acid is a potent inducer of cell cycle arrest and apoptosis and inhibits growth of colo 201 human colon cancer cells. 2004 Nutr Cancer pmid:15572300
Kato T et al. Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. 2007 Nutr Cancer pmid:17640164
Silva Jde A et al. Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. 2012 Nutr Cancer pmid:22295891
Friedrichs W et al. Omega-3 fatty acid inhibition of prostate cancer progression to hormone independence is associated with suppression of mTOR signaling and androgen receptor expression. 2011 Nutr Cancer pmid:21667400
Hajjaji N et al. DHA effect on chemotherapy-induced body weight loss: an exploratory study in a rodent model of mammary tumors. 2012 Nutr Cancer pmid:23035949
Slagsvold JE et al. DHA alters expression of target proteins of cancer therapy in chemotherapy resistant SW620 colon cancer cells. 2010 Nutr Cancer pmid:20574922
Nath RG et al. Effects of epigallocatechin gallate, L-ascorbic acid, alpha-tocopherol, and dihydrolipoic acid on the formation of deoxyguanosine adducts derived from lipid peroxidation. 2010 Nutr Cancer pmid:20574923
Hudson AG et al. Erythrocyte omega-6 and omega-3 fatty acids and mammographic breast density. 2013 Nutr Cancer pmid:23530640
Hardman WE and Ion G Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut. 2008 Nutr Cancer pmid:18791931
Roush GC et al. Modulation of the cancer susceptibility measure, adenosine diphosphate ribosyl transferase (ADPRT), by differences in low-dose n-3 and n-6 fatty acids. 1991 Nutr Cancer pmid:1837923
Cha MC et al. Dietary docosahexaenoic acid levels influence the outcome of arabinosylcytosine chemotherapy in L1210 leukemic mice. 2002 Nutr Cancer pmid:12734065
Pascale AW et al. Omega-3 fatty acid modification of membrane structure and function. II. Alteration by docosahexaenoic acid of tumor cell sensitivity to immune cytolysis. 1993 Nutr Cancer pmid:8502585
Cerchietti LC et al. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. 2007 Nutr Cancer pmid:17927497
Connolly JM et al. Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. 1999 Nutr Cancer pmid:10624705
Appel MJ and Woutersen RA Effects of a diet high in fish oil (MaxEPA) on the formation of micronucleated erythrocytes in blood and on the number of atypical acinar cell foci Induced in rat pancreas by azaserine. 2003 Nutr Cancer pmid:14769538
Rosa DD et al. Fish oil improves the lipid profile and reduces inflammatory cytokines in Wistar rats with precancerous colon lesions. 2012 Nutr Cancer pmid:22483364
Sczaniecka AK et al. Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort. 2012 Nutr Cancer pmid:23137008
DiNicolantonio JJ et al. A higher dietary ratio of long-chain omega-3 to total omega-6 fatty acids for prevention of COX-2-dependent adenocarcinomas. 2014 Nutr Cancer pmid:25356937
Yuri T et al. Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid. 2003 Nutr Cancer pmid:12881016
Hutchins-Wiese HL et al. High-dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: a pilot study. 2014 Nutr Cancer pmid:24274259
Hardman WE Dietary canola oil suppressed growth of implanted MDA-MB 231 human breast tumors in nude mice. 2007 Nutr Cancer pmid:17571951
Atkinson TG et al. DHA feeding provides host protection and prevents fibrosarcoma-induced hyperlipidemia while maintaining the tumor response to araC in Fischer 344 rats. 1997 Nutr Cancer pmid:9343830
Lytle JS et al. Stability of a commercially prepared fish oil (omega-3 fatty acid) laboratory rodent diet. 1992 Nutr Cancer pmid:1584711
Hussar DA New drugs 06, part II. 2006 Nursing pmid:16888514
Mabe H et al. [Effect of calcium entry blocker, nimodipine, on the cerebral function and metabolic recovery following experimental cerebral ischemia]. 1985 No To Shinkei pmid:2934079
Li P et al. Dietary supplementation with cholesterol and docosahexaenoic acid increases the activity of the arginine-nitric oxide pathway in tissues of young pigs. 2008 Nitric Oxide pmid:18555806
Hirafuji M et al. [Specific modulation of vascular smooth muscle cell functions by docosahexaenoic acid]. 1997 Nippon Yakurigaku Zasshi pmid:9503427
Asai M et al. [Cellular models for individualized medicine in Alzheimer's disease using patient-derived induced pluripotent stem cells]. 2014 Nippon Yakurigaku Zasshi pmid:24420133
Hashimoto M et al. [Mechanism of improvement of spatial cognition with dietary docosahexaenoic acid]. 2002 Nippon Yakurigaku Zasshi pmid:12491779
Imamura T [Ameliorative effect of n-3 fatty acid on insulin resistance through GPR120]. 2010 Nippon Yakurigaku Zasshi pmid:21313786
Hieda K et al. Pharmacological effect of functional foods with a hypotensive action. 2015 Nippon Yakurigaku Zasshi pmid:26165340
Shimakata T [Polyunsaturated fatty acid]. 2001 Nippon Rinsho pmid:11351628
Orii T et al. [Peroxisomal disorders--DNA analysis]. 1993 Nippon Rinsho pmid:8096253
Katsumata T and Katayama Y [Icosapentanoic acid (EPA), docosahexanoic acid (DHA)]. 2004 Nippon Rinsho pmid:15658280
Yoshizawa K and Tsubura A [Characteristics of N-methyl-N-nitrosourea-induced retinal degeneration in animals and application for the therapy of human retinitis pigmentosa]. 2005 Nippon Ganka Gakkai Zasshi pmid:16047940
Yui K et al. [Therapeutic effects of larger doses of arachidonic acid added to DHA on social impairment and its relation to alterations of polyunsaturated fatty acids in individuals with autism spectrum disorders]. 2011 Nihon Shinkei Seishin Yakurigaku Zasshi pmid:21800702
Amamoto T et al. [Relationship between hippocampal arachidonic acid content and induction of LTP in aged rats]. 1999 Nihon Shinkei Seishin Yakurigaku Zasshi pmid:10803212
Sasaki H et al. [Immunosuppressive effect of intravenously injected docosahexaenoic acid on single lung allotransplantation in the rat]. 1996 Nihon Kyobu Geka Gakkai Zasshi pmid:8741552
Kawabata T et al. [Comparison of long-chain polyunsaturated fatty acids in plasma and erythrocyte phospholipids for biological monitoring]. 2011 Nihon Eiseigaku Zasshi pmid:21358141
Furuya H et al. Effect of ethanol and docosahexaenoic acid on nerve growth factor-induced neurite formation and neuron specific growth-associated protein gene expression in PC12 cells. 2002 Nihon Arukoru Yakubutsu Igakkai Zasshi pmid:12462067
Ji A et al. n-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats. 2012 Neurotoxicology pmid:22406923
Yang DY et al. Detrimental effects of post-treatment with fatty acids on brain injury in ischemic rats. 2007 Neurotoxicology pmid:17854901
Kaur P et al. Docosahexaenoic acid may act as a neuroprotector for methylmercury-induced neurotoxicity in primary neural cell cultures. 2008 Neurotoxicology pmid:18619488
Kimura S et al. Docosahexaenoic acid attenuated hypertension and vascular dementia in stroke-prone spontaneously hypertensive rats. 2002 Sep-Oct Neurotoxicol Teratol pmid:12200199
Bate C et al. Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro. 2010 Neurotox Res pmid:19644728
Collins MA et al. Docosahexaenoic acid (DHA) prevents binge ethanol-dependent aquaporin-4 elevations while inhibiting neurodegeneration: experiments in rat adult-age entorhino-hippocampal slice cultures. 2013 Neurotox Res pmid:23184649
Ozsoy O et al. The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B. 2011 Neurotox Res pmid:21234736
Mills JD et al. Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury. 2011 Neurosurgery pmid:21135750
Kindler DD et al. Update on therapies for acute ischemic stroke. 2000 Neurosurg Focus pmid:16859280
Su KP Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'? 2009 Neurosignals pmid:19190401
Gomez-Pinilla F and Ying Z Differential effects of exercise and dietary docosahexaenoic acid on molecular systems associated with control of allostasis in the hypothalamus and hippocampus. 2010 Neuroscience pmid:20303394
McGahon BM et al. Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. 1999 Neuroscience pmid:10613520
Katakura M et al. Docosahexaenoic acid promotes neuronal differentiation by regulating basic helix-loop-helix transcription factors and cell cycle in neural stem cells. 2009 Neuroscience pmid:19272428
Cansev M and Wurtman RJ Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. 2007 Neuroscience pmid:17683870
Okada M et al. The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats. 1996 Neuroscience pmid:8834389
Högyes E et al. Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. 2003 Neuroscience pmid:12831859
Strokin M et al. Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2. 2006 Neuroscience pmid:16563639
Koumura A et al. A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice. 2008 Neuroscience pmid:18835333
Lu Y et al. Spinal injection of docosahexaenoic acid attenuates carrageenan-induced inflammatory pain through inhibition of microglia-mediated neuroinflammation in the spinal cord. 2013 Neuroscience pmid:23500096
Wu A et al. Exercise facilitates the action of dietary DHA on functional recovery after brain trauma. 2013 Neuroscience pmid:23811071
Horimoto N et al. Arachidonic acid activation of potassium channels in rat visual cortex neurons. 1997 Neuroscience pmid:9070743
Wu A et al. Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. 2008 Neuroscience pmid:18620024
Arnal E et al. Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex. 2010 Neuroscience pmid:20036322
Kawakita E et al. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. 2006 Neuroscience pmid:16527422
Gamoh S et al. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. 1999 Neuroscience pmid:10430487
Phivilay A et al. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. 2009 Neuroscience pmid:19135506
Dhobale M et al. Association of brain-derived neurotrophic factor and tyrosine kinase B receptor in pregnancy. 2012 Neuroscience pmid:22542551
Kotani S et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. 2006 Neurosci. Res. pmid:16905216
Cansev M et al. Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease. 2008 Neurosci. Res. pmid:18761383
Pilitsis JG et al. Free fatty acids in cerebrospinal fluids from patients with traumatic brain injury. 2003 Neurosci. Lett. pmid:12946571
Hossain MS et al. Influence of docosahexaenoic acid on cerebral lipid peroxide level in aged rats with and without hypercholesterolemia. 1998 Neurosci. Lett. pmid:9593513
Petroni A et al. The beta-oxidation of arachidonic acid and the synthesis of docosahexaenoic acid are selectively and consistently altered in skin fibroblasts from three Zellweger patients versus X-adrenoleukodystrophy, Alzheimer and control subjects. 1998 Neurosci. Lett. pmid:9708853
Yamane M and Abe A Properties of the omega-hydroxylation system of docosahexaenoic or arachidonic acid in brain or liver homogenate of rat. 1995 Neurosci. Lett. pmid:9064612
Reddy TS et al. Change in content, incorporation and lipoxygenation of docosahexaenoic acid in retina and retinal pigment epithelium in canine ceroid lipofuscinosis. 1985 Neurosci. Lett. pmid:2931631
Bourre JM and Dumont O The administration of pig brain phospholipids versus soybean phospholipids in the diet during the period of brain development in the rat results in greater increments of brain docosahexaenoic acid. 2002 Neurosci. Lett. pmid:12459515
Gazzah N et al. Evidence for brain docosahexaenoate recycling in the free-moving adult rat: implications for measurement of phospholipid synthesis. 1994 Neurosci. Lett. pmid:7824158
Sarda N et al. Docosahexaenoic acid (cervonic acid) incorporation into different brain regions in the awake rat. 1991 Neurosci. Lett. pmid:1829511
Young C et al. Cancellation of low-frequency stimulation-induced long-term depression by docosahexaenoic acid in the rat hippocampus. 1998 Neurosci. Lett. pmid:9655627
Vaidyanathan VV et al. Regulation of diacylglycerol kinase in rat brain membranes by docosahexaenoic acid. 1994 Neurosci. Lett. pmid:7845615
Alberghina M et al. Differential transport of docosahexaenoate and palmitate through the blood-retina and blood-brain barrier of the rat. 1994 Neurosci. Lett. pmid:8084474
Fonlupt P et al. Incorporation of arachidonic and docosahexaenoic acids into phospholipids of rat brain membranes. 1994 Neurosci. Lett. pmid:8084475